Cytotoxic and Schistosomidal Activities of Extract, Fractions and Isolated Compounds from Zanthoxylum Leprieurii (Rutaceae)
AbstractSchistosomiasis is a major and chronic neglected tropical disease. The existing treatment does not kill immature schistosomes and have serious adverse side effect. It is well known that some parasites are responsible for causing speciﬁc cancers in humans including bladder cancer from Schistosoma haematobium infection. So, novel drugs discovery is an urgent need. In this study, were evaluated in vitro the cytotoxic on human hepatocarcinoma (HepG2) and normal cells (Chang liver), and the schistosomicidal properties of crude extract, fractions and isolated compounds (1-Hydroxy-3-methoxy-N-methylacridone (1) described in this species from Cameroon for the first time, Scoparone (2), and Arborinine (3)) from powdered fruits of Zanthoxylum leprieurii (Rutaceae). All fractions: hexanic (FH), methylene chloride (FC), ethyl acetate (FA) and methanolic (FM) killed all the cercariae within 2 hours exposure and presents LC50 values between 2 and 3 μg/ml; Compounds 1 and 3 also displayed a good in vitro schistosomicidal activity against cercariae with LC50 values of 78.78 and 6.98 μg/mL, respectively. For antitumor activity compounds 1-3 and fraction FC presents good activity with IC50 values range 18.27 - 74.61 μg/mL on HepG2 cells, however most of these were more toxic on Chang cells than to HepG2 cells, with only exception for compound 2. The acridone Arborinine (3) can constitute a good lead for the research of schistosomiasis alternative therapy, and the coumarin Scoparone (2) can be used in drug design as scaffold for design new potential anticancer agents.
E.M. Tekwu, W.K. Anyan , D Boamah, B.A.K. Owusu, S.K. Tekwu, V.P. Beng, A.K. Nyarko , K.M. Bosompem.). “Mechanically produced schistosomula as a higher- throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends”. Biomark Research, vol. 4, pp. 1- 21, 2016.
A.C. Mafud, L.G. Fereira, Y.P. Mascarenhas, A.D. Andricopulo, Josué de Moraes. “Discovery of novel antischistosomal agents by Molecular modeling approaches” Review Trends in Parasitology, vol. 1541, 2017. Article in press.
D.G. Colley, A.L. Bustinduy, S.W. Evan, H.K. Charles. “Human Schistosomiasis”. Lancet, vol. 383, pp. 2253–2264, 2014.
D.J. Gray, D.P. McManus, Y. Li, GM Williams, R. Bergquist, A.G. Ross. “Schistosomiasis elimination: lessons from the past guide the future”. The Lancet.com/infection, vol. 20, pp. 733-736, 2010.
WHO (2015) “Schistosomiasis. A major public health problem”. World Health Organization, Geneva, Swistzerland. Available: http://www.who.int/Schistosomiasis/en/ [July 12, 2017].
A.A. Siddiqui, SZ Siddiqui. “Sm-p80-Based Schistosomiasis vaccine: Preparation for Human Clinical Trials”. Trends in parasitology, vol. 1575, 2017. Article in press.
H.L. Smits. “Prospects for the control of neglected tropical diseases by mass drug administration.” Expert Rev. AntiInfect. Ther, vol. 7, 37-56, 2009.
K. Eghan. (2011) “Evaluation of the state of Praziquantel stocks in Cameroon, Technic Report”. Strengthning Pharmaceutical Systems, pp. 1- 29. www.msh.org/sps.
G. Webbe, C.A. James. “Comparison of the susceptibility to Praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in Hamsters. Z”. Parasitenkd, vol. 52, pp. 169-177, 1977.
L.A Tchuem Tchuenté. “Control of chistosomiasis: Challenge and prospects for 21st century”. Bull Soc Pathol Exot., vol. 99, pp. 372-376, 2006.
M.J. Doenhoff; L. Pica-Mattoccia. “Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance”. Expert Rev. AntiInfect. Ther., vol. 4, pp.199-210, 2006.
N. Borros, H. Sayed, Amer, M. El-Ghannam, J.L. Benner, T.A. Day. “Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt”. Int. J. Parasitol., vol. 35, pp. 787-791, 2005.
A. Danso-Appiah, P.L. Olliaro, S. Donegan, D. Sinclair, J. Utzinger. “Drugs for treating Schistosoma mansoni infection. Culture database of systematic”. Cochrane Database of a systematic Review, issue 2, 2013. Art. No: CD000528. http://www.thecochranelibrary.com.
J. Keise, J. Utzinger. “Chemotherapy for major food-borne trematodes: a review”. Expert Opin Pharmacother, vol. 5, pp. 1711-26, 2004.
J. Jennifer Keiser; J. Chollet; S.-H. Xiao, J.-Y. Mey; P.-Y. Jiao; J. Utzinger. “Tanner M. Mefloquine-an aminoalkohol with promising antischistosomal properties in mice”. Plos Negl. Trop. Dis, vol. 3, P. 350, 2009.
Morgan JAT, Dejong RJ, Snyder SD, Mkoji GM, Loker ES. “Schistosoma mansoni and Biomphalaria: past history and future trends”. Parasitol., vol. 123, pp. S211-S228, 2001.
D. Ndjonka, L.N. Rapado; A.M. Silber; E. Liebau, C. Wrenger. “Natural Products as source for Treating Neglected Parasitic Diseases”. Int. J. Mol. Sci., vol. 14, pp. 339-3439, 2013.
E.M. Tekwu, K.M. Bosompem, W.K. Anyan, R. Appiah-Opong, O.K. Baffour-Awuah, M.D. Tettey, F. Amanfo, K. Nyarko. “In vitro assessment of Antilmintic activities of Rauwolfia vomitoria (Apocynaceae) stem bark and roots against parasitic stages of Schistosoma mansoni and cytotoxic study”. J. Parasitol. Res., pp. 1-11, 2017.
Y.O. Gamalat, M.M. Ahmed, A.K. Ahmed, A.M. Asmaa. “Biological studies on Biomphalaria alexandrina snails treated with Furcraeasellon marginata plant (family: Agavaceae) and Bacillus thuringieensiskurstaki (Dipel-2x)” J. Appl. Pharm. Sci., vol. 01, pp. 47-55, 2011.
P. Wangchuk, P.R. Giacomin, M.S. Pearson, M.J. Smout, A.l. Loukas. “Identification of lead chemotherapeutic agents from medicinal plants against blood flukes and whipworms”. Scientific reports, vol. 6, p. 32101, 2016.
L.M. Silveira de Almeida, L.S. Aleixio de Carvalho, M.C. Gazolla, S Pinto, P.L. Marcos, P. Nascimento da Silva, Josué de Moraes, S.A.D.D. Filho. “Flavonoids and sesquiterpene lactones from Artemisia absinthium and Tanacetum pathenium against Schistosoma mansoni Worms”. Evidence-Based Complementary and Alternative Medicine, pp. 1-9, 2016.
C.G. Braguine, E.S. Costa, L.G. Magalhăes, V. Rodriges, S.A. Filho , A.D. J.K. Bastos, A.S. Màrciol, W.R. Cunha, A.H. Januàrio, P.M.. Pauletti. “Schistosomicidal evaluation of Zanthoxylum naranjillo and its isolated compounds against Schistosoma mansoni Adult worms”. Verlag der Zeitschriftfür Naturforschung Tübingen, vol. 64c, pp. 793-797, 2009.
C.G. Braguine, C.S. Bertanha, U.O. Gonçalves, L.G. Magalhăes, V. Rodrigues, V.M. Gimenez, M. Groppo, P.P. Mendonça. “Schistosomicidal evaluation of flavonoids from two species of Styrax against Schistosoma mansoni Adult Worms”. Pharmaceutical Biology, vol. 50, pp. 925-929, 2012.
T.A. Alvarenga, T.R. Bêto, C.G. Braguine, U.O. Gonçalves, L.G. Magalhaăes, V. Rodrigues, V.M. Gimenez, M. Groppo, A. Luis, M. Silva, R.C. Wilson, A.H. Januảrio, P.M. Pauletti. “Evaluation of Cuspididaro apulcha and its isolated compounds against Schistosoma mansoni adult worms”. International Journal of Biotechnology for Wellness Industries, vol. 1, pp. 122-127, 2012.
L.A. Toumno. “Gestion intégrée des principaux insectes ravageurs des céréales par l’utilisation des métabolites secondaires des plantes indigènes du Sénégal et de Centrafrique”. PhD Thesis, The University Cheikh Anta Diop, Sénégal, 2013.
A.T. Tchinda, V. Fuendjiep, A. Sajjad, C. Matchawe, P. Wafo, S. Khan, P. Tane, I.C. Muhammad. “Bioactive compounds from fruits of Zanthoxylum leprieurii”. Pharmacologyonline, vol. 1, pp. 406-415, 2009.
C. Thouvenel, J.C. Gantier, P. Duret, C. Fourneau, R. Hocquemiller, M.E. Ferreira, A. Rojas de Arias, A. Fournet. “Antifungal compounds from Zanthoxylum chiloperone var. angusifolium”. Phytother. Res., vol. 17, pp. 678-680, 2013.
F. Bevalot, A. Fournet, C. Moretti, J. Vaquette. “Alkaloids from Esenbeckia pilocarpoides”. Planta Med., vol. 50, pp. 522-523, 1984.
R. Hänsel, Cybulski. “Alkaloids from the root back t of Vepris pilosa” Arch. Pharm. (Weinheim), vol. 311, pp. 135-138, 1978.
W. Tian-Shung, F. Hiroshi. “Acridone Alkaloids. Part 9.1 Chemical Constituents of Glycosmis citrifolia (Willd) Lindl. Structure elucidation of novel linear pyranoacridones furoacridones, and other new acridone alkaloids”. Chem. Soc. Perkin Trans I., pp. 1681-1688, 1983.
S.K. Adesina. “Further new constituents of Zanthoxylum leprieurii”. Fitoterapia, vol. 58, pp. 123-126, 1987.
H .Fouotsa, A.T. Mbaveng, C.D. Mbazoa, A.E. NKengfack, I.C. Farzana, J.J.M. Meyer, l. L. Kuete. “Antibacterial constituents of three Cameroonian medicinal plants: Garcinia nobilis, Oriciasuaveolens and Balsamocitrus camerunensis”. BMC Complementery and Alternative Medicine, vol. 13, pp. 81-91, 2013.
Y. Furukawa, H. Takeuchi, I. Harada. M. Tasumi. “Matrix-isolation infrared and ultraviolet spectroscopic studies of less stable conformers of 1,3,5-hexatriene”. Journal of Molecular Structure, vol. 100, pp. 341-350, 1983.
F. Fish, P.G. Waterman. “Alkaloids from two Nigerian species of Fagara”. J. Pharm Pharmac., vol. 23, pp.132S-135S, 1911.
L. Bunalema, F.G. Wabo, P. Waako, J. Tabuti, S.O. Yeboah. “Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis “. BMC. Complement Altern Med., vol. 17, P. 89, 2017.
S. EGengaihi, A.M. Mohamed, M.A. Selim, H.M. Motawe. “Biological and chemical studies of some saponins having antimolluscal activity”. Egypt J. Bilh. , vol. 10, pp. 127-133, 1988.
L.J. McGaw, E.E. Elgorashi, J.N. Eloff. “Cytotoxicity of African Medicinal Plants Against Normal Animal and Human Cells. Toxicological Survey of African Medicinal Plants”. 1st edition, V. Kuete. Ed Elsevier London; Elsevier Ins., 2014, 742Pages.
P.J. Hotez, M. Alvarado, M-G. Basáñez, I. Bolliger, B. Rupert, M. Boussinesq, S.J. Brooker, A.S. Brown, G. Buckle, C.M. Budke, H. Carabin, L.E. Coffeng, E.M. Fèvre, T. Fürst, Y.A. Halasa, R. Jasrasaria, N.E. Johns, J. Keiser, C.H. King, R. Lozano, M.E. Murdoch S. O'Hanlon, S.D.S. Pion, R.L. Pulla, K.D. Ramaiah, T. Roberts, D.S. Shepard, J.L. Smith, W.A. Stolk, E.A. Undurraga, J. Utzinger, M. Wang, C.J.L. Murray, M. Naghavi. “The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases”. PLos Negl. Trop. Dis., vol. 8, p. e2865, 2014.
C. Machicado, L.A. Marcos. () “Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis”. A systematic review. Int. J. Cancer, vol. 138, pp. 2915–2921, 2016.
A. Wibowo, N. Ahmat, A.S. Hamzah, A.S. Sufian, N.H. Ismail, R. Ahmad, F.M. Jaafar, H. Takayama, A. Malaysianol. “A new trimer resveratrol oligomer from the stem bark of Drybalanops aromatic”. Fitoterapia, vol. 82, pp. 676-681, 2011.
R.S. Katiyar, N.R. Singhvi, R.V. Kushwaha, .L Ramji, N. Suryanarayana. “VA-mycorrhizal association in arjuna trees in forest of Bhandara region, Maharashtra”. India International Journal of Agricultural Sciences, vol. 4, pp. 229-232, 2009.
S.K. Mantena, S.D. Sharma, S.K. Katiyar. “Berberine, a natural product, induces GI-phase cell cycle arrest and caspase-3-dependent apoptosis in humanprostate carcinoma cells”. Molecular Cancer Therapeutics, vol. 5, pp. 296-308, 2006a.
M.F. El-Saway, J .Duncan, S. Amer, H. El-Ruweini, N. Brown. “The molluscicidal, properties of A. Maritima L. “(Composite). 4-Temporal and special distribution of B. alexandrina in Egyptian village irrigation system with reference to schistosomiasis transmission control”. Trop. Med. Parasitol., vol. 40, pp. 103-106, 1989.
D.M. Parkin, F. Bray, J .Ferlay, P. Pisani. “Global cancer statistics”. CMA Cancer J. Clin., vol. 55, pp. 74-108, 2004.
M.H. Tieten, M. Dicato, M. Diedericch. “Hybrid Curcumin compounds: a new strategy for cancer treatment”. Molecules, vol. 19, pp. 20839-20863, 2014.
T. Bruneton. “Phytochemistry and pharmacology of medicinal plants: Technics”. 2nd edition, Lavoisier, Paris, 1993, .pp. 309-332.
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.